跳到正文
原文
Medical Xpress·· 1 天前AI 评分45

天然化合物衍生物FP在多发性硬化小鼠模型中促进神经再生并改善瘫痪症状

Novel compound eases paralysis and activates nerve repair pathways in multiple sclerosis mouse model

AI 导读

美国伊利诺伊大学香槟分校与日本庆应义塾大学、千叶大学合作研究发现,天然化合物衍生物furapyrrodole(FP)可在多发性硬化小鼠模型中减轻瘫痪症状并激活中枢神经系统再生通路,相关成果发表于Advanced Science。

正文
Novel compound improves paralysis, neural regeneration in a mouse model of MS
Mode of action of Notch inhibition by FP. Credit: Advanced Science (2026). DOI: 10.1002/advs.78560

A new derivative of a natural compound reduced symptoms associated with multiple sclerosis and promoted the central nervous system's regenerative pathways in a mouse model, report researchers at the University of Illinois Urbana-Champaign and collaborators at Keio University and Chiba University in Japan.

The compound activates a mitochondrial enzyme that regulates a cellular signaling pathway key for regeneration. The researchers saw improvements in paralysis and changes associated with neural regeneration in the mice, pointing to the compound furapyrrodole, or FP, as a possible drug candidate for further study. The findings are published in the journal Advanced Science.

"It may be possible to stimulate the body's own repair mechanisms to restore damaged nerve cells and myelin in MS," said Makoto Inoue, an Illinois professor of comparative biosciences who co-led the work with professors Midori Arai of Keio University and Takayoshi Arai of Chiba University. "Our findings identify FP as a promising compound that may help unlock this natural regenerative potential."

Targeting the brain's repair pathways

MS is a neurodegenerative disease in which the immune system attacks and damages the myelin sheaths that cover and protect neurons of the central nervous system. Although treatments are available to suppress relapses and progression, no established therapies can adequately restore neurons or neurological functions that have already been lost.

The research team wanted to find a candidate for treatment that could achieve some functional recovery for MS by promoting the differentiation of neural stem or progenitor cells, which reside in the adult brain and spinal cord, into neurons and myelin-forming cells. They focused on the Notch signaling pathway, which suppresses the differentiation of neural stem or progenitor cells into neurons.

"Inhibition of Notch signaling may help generate neurons and could be an effective therapy for neurodegenerative diseases, including multiple sclerosis," said Inoue, who also is affiliated with the neuroscience program at the U. of I.

An indirect route to Notch inhibition

However, conventional Notch inhibitors are associated with adverse gastrointestinal effects. So the researchers set out to screen compounds derived from natural products that could indirectly suppress Notch signaling by binding with an intermediary.

Using specialized cells developed by the Keio group to measure Notch activity, the research team screened the Chiba chemical library and identified Notch-inhibitory activity in a class of compounds called spirooxindoles. After synthesizing and further screening derivatives, they identified FP as the most promising candidate.

The researchers found that FP targets a mitochondrial enzyme, CYB5R3, and enhances its enzymatic activity. This activation resulted in hyperpolarization of the mitochondrial membrane and a reduction in calcium ion levels in the cell. Consequently, this reduced the activity of a calcium-dependent enzyme that plays a key role in Notch signaling.

Motor improvements without intestinal side effects

Inoue's group at Illinois then tested FP in a mouse model of MS. The mice demonstrated improvements in movement and lessened paralysis. In the spinal cord, suppression of Notch signaling was accompanied by increased numbers of motor neurons derived from neural progenitor cells and oligodendrocytes, cells that contribute to myelin repair. In addition, Inoue's team found that FP suppressed inflammation in the central nervous system, which is associated with the progression of MS.

Importantly, FP showed no intestinal side effects because its target, CYB5R3, is highly expressed in neural progenitor cells but only expressed at very low levels in the intestine.

Future studies are needed to further investigate the efficacy, safety and pharmaceutical properties of FP to explore its potential therapeutic applications in MS and other neurological disorders, such as Alzheimer's disease and amyotrophic lateral sclerosis, Inoue said. The researchers plan to continue exploring its action in mice and neural tissue cultures before moving forward to other models.

"Our findings suggest that FP promotes remyelination by stimulating neural progenitor cells to differentiate into oligodendrocytes," Inoue said. "In addition, its regenerative effects may support the recovery of damaged neuronal populations. Together, these effects were associated with improved motor function in the mouse model, suggesting that targeting the body's own regenerative mechanisms may offer a promising therapeutic strategy for restoring neurological function in MS."

Publication details

Yuki Narushima et al., Targeting Mitochondrial Redox Signaling Promotes Neuroregeneration and Functional Recovery in a Multiple Sclerosis Model, Advanced Science (2026). DOI: 10.1002/advs.78560

Journal information: Advanced Science

Who's behind this story?

Lisa Lock

Lisa Lock

BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Novel compound eases paralysis and activates nerve repair pathways in multiple sclerosis mouse model (2026, November 18) retrieved 18 November 2026 from https://medicalxpress.com/news/2026-11-compound-eases-paralysis-nerve-pathways.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com